ELAN logo

Elanco Animal Health Incorporated (ELAN)

$22.69

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on ELAN

Market cap

$11.34B

EPS

-0.4

P/E ratio

--

Price to sales

2.28

Dividend yield

--

Beta

1.705119

Price on ELAN

Previous close

$22.55

Today's open

$22.43

Day's range

$22.35 - $22.84

52 week range

$19.40 - $27.98

Profile about ELAN

CEO

Jeffrey N. Simmons

Employees

9450

Headquarters

INDIANAPOLIS, IN

Exchange

New York Stock Exchange

Shares outstanding

499621830

Issue type

Common Stock

ELAN industries and sectors

Healthcare

Pharmaceuticals

News on ELAN

Elanco Animal Health Appoints Jamie Preston as Chief People Officer

Preston brings more than two decades of global HR leadership and workforce innovation experience; Dave Kinard to retire at year-end INDIANAPOLIS, Oct. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced the appointment of Jamie Preston as Executive Vice President and Chief People Officer, effective November 3rd. Preston's appointment follows an extensive and competitive search as part of the company's commitment to attract, develop and retain an engaged global workforce while embedding inclusion, well-being and purpose into daily operations.

news source

PRNewsWire • Oct 22, 2026

news preview

Will Elanco Animal Health (ELAN) Beat Estimates Again in Its Next Earnings Report?

Elanco Animal Health (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

news source

Zacks Investment Research • Oct 19, 2026

news preview

What Growing Up on a Farm Taught Elanco's CEO

One of Jeff Simmons' pivotal leadership lessons came when he was 7 years old. Now CEO of Elanco Animal Health, Simmons said his family's upstate New York grape farm had been devastated by a hailstorm. It was the first time he saw his father cry.

news source

WSJ • Oct 8, 2026

news preview

Elanco Animal Health Eyes Growth, Deleveraging as Quattro and Zenrelia Gain Ground

Elanco Animal Health NYSE: ELAN President and CEO Jeff Simmons outlined the company's growth strategy, product launches, deleveraging plans and outlook for its pet health and farm animal businesses during the Bank of America Healthcare Conference in London.

news source

MarketBeat • Sep 26, 2026

news preview

Elanco Animal Health Incorporated (ELAN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Elanco Animal Health Incorporated (ELAN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

news source

Seeking Alpha • Sep 22, 2026

news preview

Elanco to Participate in BofA Securities Global Healthcare Conference 2026

INDIANAPOLIS, Sept. 17, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the BofA Securities Global Healthcare Conference 2026 on September 22, 2026.

news source

PRNewsWire • Sep 17, 2026

news preview

Elanco Animal Health Incorporated (ELAN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Elanco Animal Health Incorporated (ELAN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

news source

Seeking Alpha • Sep 15, 2026

news preview

Expanding Tick and Itch Season Supports Momentum in Elanco Innovation, Meeting Pet Owner Demand for Health and Wellness Care

Innovation that protects against these pests is driving stronger Elanco base business and overall share gains. Elanco confirms U.S. Pet Health is on track to expectations of high-single digit to low double-digit growth in the second half of 2026.

news source

PRNewsWire • Sep 15, 2026

news preview

Elanco Confirms Date and Conference Call for Third Quarter 2026 Financial Results Announcement

INDIANAPOLIS, Sept. 11, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its third quarter 2026 financial results on Friday, November 6, 2026.

news source

PRNewsWire • Sep 11, 2026

news preview

Elanco to Participate in Morgan Stanley 24th Annual Global Healthcare Conference

INDIANAPOLIS, Sept. 10, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026.

news source

PRNewsWire • Sep 10, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Elanco Animal Health Incorporated

Open an M1 investment account to buy and sell Elanco Animal Health Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in ELAN on M1